Matthew Reynolds to Retrospective Studies
This is a "connection" page, showing publications Matthew Reynolds has written about Retrospective Studies.
Connection Strength
1.263
-
Zeitler EP, Bian B, Griffiths RI, Allocco DJ, Christen T, Roy K, Cohen DJ, Reynolds MR. Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2024 Oct; 17(10):e011007.
Score: 0.096
-
Reynolds MR, Passman R, Swindle J, Mohammadi I, Wright B, Boyle K, Turakhia MP, Mittal S. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024 03; 269:25-34.
Score: 0.090
-
Reynolds MR, Bunch TJ, Steinberg BA, Ronk CJ, Kim H, Wieloch M, Lip GYH. Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data. J Cardiovasc Electrophysiol. 2023 04; 34(4):790-799.
Score: 0.085
-
Sutton BS, Bermingham SL, Diamantopoulos A, Rosemas SC, Tsintzos SI, Xia Y, Reynolds MR. Economic value of insertable cardiac monitors in unexplained syncope in the United States. Open Heart. 2021 02; 8(1).
Score: 0.074
-
Griffiths RI, Amorosi SL, Jacobsen CM, McBee PJ, Menzin J, Reynolds MR. Costs and complications associated with transvenous lead reoperation in cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2020 02; 31(2):503-511.
Score: 0.069
-
Reynolds MR, Allison JS, Natale A, Weisberg IL, Ellenbogen KA, Richards M, Hsieh WH, Sutherland J, Cannon CP. A Prospective Randomized Trial of?Apixaban Dosing During Atrial?Fibrillation?Ablation: The?AEIOU Trial. JACC Clin Electrophysiol. 2018 05; 4(5):580-588.
Score: 0.060
-
Turakhia MP, Zweibel S, Swain AL, Mollenkopf SA, Reynolds MR. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks. Circ Cardiovasc Qual Outcomes. 2017 02; 10(2).
Score: 0.056
-
Reynolds MR, Buckley RT, Indrakanti SS, Turkmani AH, Oh G, Crobeddu E, Fargen KM, El Ahmadieh TY, Naidech AM, Amin-Hanjani S, Lanzino G, Hoh BL, Bendok BR, Zipfel GJ. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms. J Neurosurg. 2015 Oct; 123(4):862-71.
Score: 0.051
-
Chyou JY, Hunter TD, Mollenkopf SA, Turakhia MP, Reynolds MR. Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients. J Am Heart Assoc. 2015 Jul 23; 4(7).
Score: 0.051
-
Hao SC, Hunter TD, Gunnarsson C, March JL, White SA, Ladapo JA, Reynolds MR. Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation. J Interv Card Electrophysiol. 2012 Nov; 35(2):173-82.
Score: 0.041
-
Reynolds MR, Gunnarsson CL, Hunter TD, Ladapo JA, March JL, Zhang M, Hao SC. Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis. Circ Cardiovasc Qual Outcomes. 2012 Mar 01; 5(2):171-81.
Score: 0.040
-
Kleinman NL, Rohrbacker NJ, White SA, March JL, Reynolds MR. Economic impact to employers of treatment options for cardiac arrhythmias in the US health system. J Occup Environ Med. 2011 Apr; 53(4):405-14.
Score: 0.038
-
Reynolds MR, Ray WZ, Strom RG, Blackburn SL, Lee A, Park TS. Clinical outcomes after selective dorsal rhizotomy in an adult population. World Neurosurg. 2011 Jan; 75(1):138-44.
Score: 0.037
-
Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm. 2009 Sep; 6(9):1267-73.
Score: 0.033
-
Ferro EG, Reynolds MR, Xu J, Song Y, Cohen DJ, Wadhera RK, d'Avila A, Zimetbaum PJ, Yeh RW, Kramer DB. Contemporary Administrative Codes to Identify Pulmonary Vein Isolation Procedures for Atrial Fibrillation. J Am Heart Assoc. 2025 Jan 21; 14(2):e037003.
Score: 0.024
-
Aglan A, Fath AR, Maron BJ, Maron MS, Prasad A, Almomani A, Hammadah M, Reynolds MR, Rowin EJ. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 2024 09; 21(9):1677-1683.
Score: 0.023
-
Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J. 2003 Feb; 145(2):334-42.
Score: 0.021
-
Reynolds MR, Rinaldi MJ, Pinto DS, Cohen DJ. Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol. 2002 Jul; 14(7):364-8.
Score: 0.020
-
Africk BN, Heiferman DM, Wozniak AW, Behzadi F, Ballard MS, Chazaro JM, Zsigray BM, Shanker RM, Reynolds MR, Anderson DE, Serrone JC. Angioarchitectural features amongst patients with unruptured brain arteriovenous malformations presenting with headache: findings from a single center retrospective review of 76 patients. J Headache Pain. 2021 Oct 09; 22(1):122.
Score: 0.019
-
Witte KK, Tsivgoulis G, Reynolds MR, Tsintzos SI, Eggington S, Ismyrloglou E, Lyon J, Huynh M, Egea M, de Brouwer B, Ziegler PD, Franco N, Joglekar R, Rosemas SC, Liu S, Thijs V. Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation. BMC Cardiovasc Disord. 2021 03 31; 21(1):160.
Score: 0.019
-
Carbuhn AF, Sanchez Z, Fry AC, Reynolds MR, Magee LM. A Simplified Prediction Model for Lower Extremity Long Bone Stress Injuries in Male Endurance Running Athletes. Clin J Sport Med. 2020 09; 30(5):e124-e126.
Score: 0.018
-
Barker CM, Reardon MJ, Reynolds MR, Feldman TE. Association Between Institutional Mitral Valve Procedure Volume and Mitral Valve Repair Outcomes in Medicare Patients. JACC Cardiovasc Interv. 2020 05 11; 13(9):1137-1139.
Score: 0.017
-
Culler SD, Kugelmass AD, Cohen DJ, Reynolds MR, Katz MR, Brown PP, Schlosser ML, Simon AW. Understanding Readmissions in Medicare Beneficiaries During the 90-Day Follow-Up Period of an Acute Myocardial Infarction Admission. J Am Heart Assoc. 2019 11 05; 8(21):e013513.
Score: 0.017
-
Cannon CP, Sanchez RJ, Klimchak AC, Khan I, Sasiela WJ, Reynolds MR, Rosenson RS. Simulation of the Impact of Statin Intolerance on the Need for Ezetimibe and/or Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor for Meeting Low-Density Lipoprotein Cholesterol Goals in a Population With Atherosclerotic Cardiovascular Disease. Am J Cardiol. 2019 04 15; 123(8):1202-1207.
Score: 0.016
-
Culler SD, Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Katz MR, Schlosser ML, Simon AW. Impact of Complications on Resource Utilization During 90-Day Coronary Artery Bypass Graft Bundle for Medicare Beneficiaries. Ann Thorac Surg. 2019 May; 107(5):1364-1371.
Score: 0.016
-
Arnold SV, Li Z, Vemulapalli S, Baron SJ, Mack MJ, Kosinski AS, Reynolds MR, Hermiller JB, Rumsfeld JS, Cohen DJ. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry. JAMA Cardiol. 2018 12 01; 3(12):1151-1159.
Score: 0.016
-
Culler SD, Cohen DJ, Brown PP, Kugelmass AD, Reynolds MR, Ambrose K, Schlosser ML, Simon AW, Katz MR. Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has?Transcatheter Aortic Valve Replacement?Made a Difference? Ann Thorac Surg. 2018 04; 105(4):1137-1143.
Score: 0.015
-
Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber DJ. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018 03; 15(3):355-362.
Score: 0.015
-
Baron SJ, Arnold SV, Reynolds MR, Wang K, Deeb M, Reardon MJ, Hermiller J, Yakubov SJ, Adams DH, Popma JJ, Cohen DJ. Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial. Am Heart J. 2017 Dec; 194:39-48.
Score: 0.015
-
Arnold SV, Spertus JA, Vemulapalli S, Li Z, Matsouaka RA, Baron SJ, Vora AN, Mack MJ, Reynolds MR, Rumsfeld JS, Cohen DJ. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry. JAMA Cardiol. 2017 04 01; 2(4):409-416.
Score: 0.014
-
Arias EJ, Vajapey S, Reynolds MR, Chicoine MR, Rich KM, Dacey RG, Dorward IG, Derdeyn CP, Moran CJ, Cross DT, Zipfel GJ, Dhar R. Utility of Screening for Cerebral Vasospasm Using Digital Subtraction Angiography. Stroke. 2015 Nov; 46(11):3137-41.
Score: 0.013
-
Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):437-46.
Score: 0.013
-
Pinto DS, Kohli P, Fan W, Kirtane AJ, Kociol RD, Meduri C, Deliargyris EN, Prats J, Reynolds MR, Stone GW, Michael Gibson C. Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database. Catheter Cardiovasc Interv. 2016 Feb 15; 87(3):363-73.
Score: 0.012
-
Culler SD, Kugelmass AD, Brown PP, Reynolds MR, Simon AW. Trends in coronary revascularization procedures among Medicare beneficiaries between 2008 and 2012. Circulation. 2015 Jan 27; 131(4):362-70; discussion 370.
Score: 0.012
-
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014 Sep 23; 130(13):1037-43.
Score: 0.012
-
Arnold SV, Reynolds MR, Lei Y, Magnuson EA, Kirtane AJ, Kodali SK, Zajarias A, Thourani VH, Green P, Rod?s-Cabau J, Beohar N, Mack MJ, Leon MB, Cohen DJ. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation. 2014 Jun 24; 129(25):2682-90.
Score: 0.012
-
Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014 Jun 15; 113(12):2052-6.
Score: 0.012
-
Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013 Apr; 10(4):e59-65.
Score: 0.011
-
Abdelhadi RH, Saba SF, Ellis CR, Mason PK, Kramer DB, Friedman PA, Gura MT, DiMarco JP, Mugglin AS, Reynolds MR, Bazaz RR, Retel LK, Hayes DL, Hauser RG. Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm. 2013 Mar; 10(3):361-5.
Score: 0.010
-
Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT, Moran CJ. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg. 2013 Jul; 5(4):337-43.
Score: 0.010
-
Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Burk C. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011 Feb; 4(1):15-25.
Score: 0.009
-
Tung R, Josephson ME, Reddy V, Reynolds MR. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol. 2010 Jul; 21(7):799-803.
Score: 0.009
-
Culler SD, Simon AW, Brown PP, Kugelmass AD, Reynolds MR, Rask KJ. Sex differences in hospital risk-adjusted mortality rates for Medicare beneficiaries undergoing CABG surgery. Arch Intern Med. 2008 Nov 24; 168(21):2317-22; discussion 2323-5.
Score: 0.008
-
Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008 Jun; 85(6):1980-6.
Score: 0.008
-
Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol. 2006 Sep; 17(9):940-3.
Score: 0.007